Pfizer’s Chantix still getting the slow-burn investigation by the regulators - Federal regulators are still investigating the safety of Pfizer’s anti-smoking drug Chantix, a probe that beg… more →
Impactiviti blogdrppros wrote 2 weeks ago: Direct Response Pros, Inc. July 1, 2009 “Our Success is Measured by your Profitabili … more →
timeinctemp wrote 1 month ago: FRIDAY, June 5 (HealthDay News) — The diabetes drug Avandia significantly raises the risk of both he … more →
Steve Woodruff wrote 1 month ago: Pfizer’s Chantix still getting the slow-burn investigation by the regulators - Federal regulat … more →
victoriasexmovie wrote 1 month ago: Medical information about Diabetes Mellitus, Type 2, Type 1, and Metabolic Disorders treatment and m … more →
aguileravideo wrote 2 months ago: Medical information about Diabetes Mellitus, Type 2, Type 1, and Metabolic Disorders treatment and m … more →
timeinctemp wrote 3 months ago: THURSDAY, April 16 (HealthDay News) — Many patients who stopped using the diabetes drug rosiglitazon … more →
sakerfa wrote 3 months ago: Well we knew it was the case all along but this week there are emails released as part of Vioxx liti … more →
nmgtomkat wrote 4 months ago: Metformin (Glucophage®): decreases hepatic (liver) glucose production decreases intestinal absorpti … more →
Drug Recall Watch wrote 6 months ago: The U.S. Food and Drug Administration is now asking all companies looking for approval of new type 2 … more →
Steve Woodruff wrote 7 months ago: General news: Approvals: Genzyme’s stem cell transplant drug Mozobil; Abbott’s triglyce … more →
briankherrington wrote 7 months ago: If you or someone you know is currently taking Avandia, please read the article below for important … more →
timeinctemp wrote 7 months ago: MONDAY, Nov. 24 (HealthDay News) — The widely used diabetes drug Avandia — already controversial bec … more →
ogangurel wrote 8 months ago: via Thinking about Life Sciences: FDA: Tortoise, Hare or Something Else … more →
ogangurel wrote 8 months ago: via Thinking about Life Sciences: Avandia, the Drug Safety Debate and How to Get a Nobel Prize … more →
ogangurel wrote 8 months ago: via Thinking about Life Sciences: FDA Report on Avandia: Implications and a “critique” o … more →
ogangurel wrote 8 months ago: An FDA panel voted 22 to 1 on Monday (7/30) to keep Avandia on the market; the vote on the heart att … more →
timeinctemp wrote 8 months ago: THURSDAY, Oct. 30 (HealthDay News) — The diabetes drug Avandia should be banned in the United States … more →
Bunny Ellerin wrote 10 months ago: Manhattan Research, a data fave of mine, recently published another of its many studies related to t … more →
Editor wrote 10 months ago: A number of related drugs for type 2 diabetics may increase their risk of heart failure, a Wake Fore … more →